Lung Cancer: A Growing Concern

Lung cancer remains the leading cause of cancer-related deaths in the U.S., surpassing deaths from prostate and colon cancers together, and nearly three times that of breast cancer. Despite its high mortality rate, awareness and screening for lung cancer lag behind other forms of cancer. Many still associate it primarily with heavy smokers, although the reality is much more complex.

Advancements in technology provide a better chance of early detection, which is crucial for effective treatment. However, existing screening guidelines often miss identifying those at risk, leading to only about 20% of eligible individuals getting screened. This may be partially due to entrenched misconceptions surrounding lung cancer.

Juliet DuBois found out she had lung cancer two years ago after undergoing a hip replacement at 46. A blood test post-surgery indicated possible complications, prompting further investigation that revealed a mass in her lung.

DuBois reflects on her situation with mixed feelings: “Was I lucky for discovering it, or was I unfortunate for needing a hip replacement?” she pondered.

Prior to her operation, she experienced some discomfort but had dismissed it as fatigue, failing to connect it as a potential warning sign.

After undergoing chemotherapy, DuBois describes her current health as “pretty good” and has even enrolled in an online MBA program, something she had always dreamed of. “Honestly, going back to school seems less daunting than battling cancer,” she noted.

Her family background may have contributed to her decision to avoid smoking, as both parents were heavy smokers. She questions whether she would have considered lung cancer screening if it had been suggested to her.

Interestingly, a significant portion—up to 25%—of lung cancer cases occur in individuals who have never smoked. It’s even more prevalent in women than men, particularly among those of East Asian or South Asian descent.

Albertha “Bertie” Gethers, who began smoking at a young age, maintained a light smoking habit for over five decades. Despite this, she never underwent lung cancer screening due to not meeting the official guidelines for high-risk individuals, which left her reliant on external recommendations.

In 2024, a friend informed her about a research program offering free CT scans to Black women aged 50 to 80. Gethers participated and was shocked to discover multiple cancerous lesions in her lungs. Thankfully, a surgeon successfully removed them.

This program, known as the “INSPIRE” study, aims to assess lung cancer screening’s feasibility for Black patients regardless of their smoking history. Unfortunately, these patients often go unscreened, even though they face a higher mortality risk from lung cancer.

A majority of lung cancer cases arise in individuals who fall outside the existing screening criteria, meaning they are often diagnosed too late or incidentally when seeking medical attention for unrelated issues.

Experts explain that risk factors like air quality, genetic predisposition, and smoking habits all play a role in lung cancer development. Yet, the rigid “20-pack-years” criterion excludes many vulnerable individuals from screening.

Standard low-dose CT scans are the main method for lung cancer screening. They utilize minimal radiation to create 3D images of the lungs. However, costs and potential unnecessary procedures have led organizations to recommend screening only for those at highest risk.

Dr. Jessica Donington from the University of Chicago criticizes current screening classifications as overly narrow. Guidelines have only recently started evolving, allowing for more individuals who may benefit from screening.

Although some major organizations updated their recommendations in 2022, the US Preventive Services Task Force has not revisited their criteria since 2021, causing concern among health professionals.

When low-dose CT scans were initially introduced, they detected early-stage cancers but didn’t significantly reduce mortality rates. Consequently, many healthcare providers hesitated to endorse them widely.

However, a pivotal study in 2011 demonstrated a 20% drop in death rates among patients screened with low-dose CT, leading to wider acceptance and insurance coverage for these scans.

Today, a measured approach is more common; if a nodule is found, it usually leads to monitoring rather than immediate surgery, allowing for a more cautious method of identifying true threats.

Yang, who lost his grandfather to lung cancer before CT scans became prevalent, has dedicated his career to helping lung cancer patients. His personal experiences motivate him to push for better screening practices.

Loryn Fadus, at 34, was also taken by surprise when her CT scan revealed cancer. Unbeknownst to her, fatigue she attributed to motherhood masked a much graver issue. Only through persistence in seeking medical advice did she finally receive proper care.

With more than 10% of new lung cancer patients under 55, the disease is increasingly diagnosed at advanced stages, particularly among younger demographics. Among those under 40, women make up a significant percentage of cases.

For younger patients, cancer is generally diagnosed later, often when more aggressive treatment is necessary. Statistics show a much lower survival rate for late-stage diagnoses compared to early detection.

Kelley Jones, also facing an unexpected diagnosis, noticed a change in her nails—a common yet often overlooked symptom. After some prodding from her sister, she consulted a specialist and discovered her condition early, which is quite rare and a stroke of luck given her insurance coverage.

Jones reflects on the trials she’s faced: “It’s astounding how quickly things could have turned out differently. That CT scan? It was the lifesaver I didn’t know I needed.”

While chronic cough, weight loss, and other symptoms are typically associated with lung cancer, some patients also present uncommon signs, particularly younger adults experiencing neurological issues.

Recent advancements in AI technology may enhance cancer risk assessments beyond existing guidelines. A program called Sybil can analyze CT scans and assign a risk score related to lung cancer development.

In trials, Sybil has proven to be quite effective in accurate risk assessments, which could revolutionize early detection methods.

This AI approach aims for timely interventions by stratifying patients into risk categories, potentially allowing for personalized screening schedules tailored to individual needs.

Sequist emphasizes the importance of moving away from smoking-focused criteria, enhancing lung cancer screening protocols for diverse populations.